Pharma Science

Practical HPLC for Biopharmaceuticals – Training Module 1: Isocratic HPLC Basics

Although “small molecule” and “biopolymer” separations have traditionally been considered as separate activities, analysts in the biopharmaceutical industry regularly have to deal with both. Fortunately, the underlying principles of...

Trends in IC for pharmaceutical analysis - expert interview, part 2

This is the second part of our discussion with Dr Jeffrey Rohrer, Director of Applications for ion chromatography (IC) products at Thermo Fisher Scientific for his thoughts on the evolving role of IC in regulated pharmaceutical analysis...

Determination of Leachables in Orally Inhaled and Nasal Drug Products (OINDP) by GC/MS-MS

Shimadzu has produced an application note describing a highly sensitive method for the quantitation of 40 leachables in OINDP products by GC/MS-MS.

New Mass Spectrometer Platform Offers Greater Quantitative Sensitivity, Speed and Reproducibility

New Q Exactive HF-X Orbitrap mass spectrometer enables scientists to advance disease research and drug discovery.

Phospholipid Analysis for Four Types of Mouse Tissues using Triple Quadrupole LC-MS/MS with SimLipid

Shimadzu has produced an application note describing phospholipid analysis for four types of mouse tissues performed by precursor ion scan (PIS) or neutral loss scan (NLS) with a triple quadrupole mass spectrometer.

How can light scattering can improve your GPC/SEC

Learn about the advantages and benefits of light scatttering techniques and how they can help your analysis of polymeric excipients.

High-Sensitivity Analysis of Residual Solvents in Drug Products - USP <467> Residual Solvents Procedure A

Shimadzu has produced an application note presenting data obtained from Class 1 and Class 2 standard solutions, in accordance with Water-Soluble Articles, Procedure A, in USP <467> Residual Solvents.

High Speed LC Analysis of Pharmaceutical Impurities in Compliance with European Pharmacopoeia

Shimadzu has produced an application note describing a newly developed method for the high-speed analysis of pharmaceuticals and related substances in compliance with European Pharmacopoeia using the Nexera-i MT.

Trends in IC for pharmaceutical analysis - expert interview, part 1...

We talked with Dr Jeffrey Rohrer, Director of Applications for ion chromatography (IC) products at Thermo Fisher Scientific for his thoughts on the evolving role of IC in regulated pharmaceutical analysis...

Monitoring VOC Emissions from Respiratory Medical Devices in Accordance with ISO 18562

Markes International has produced an application note describing the monitoring of potentiallyharmful volatile and semi-volatile organic compounds (VOCs and SVOCs) emitted from respiratory medical devices, in accordance with the recently-released...

Transition to modernized pharmacopoeial methods using ion chromatography

Many existing pharmaceutical and biopharmaceutical assays are time consuming, labor-intensive, involve hazardous chemicals, require extensive analyst training, and may yield significant measurement errors.

Current Methodologies for Drugs of Abuse Urine Testing

Biotage has produced a white paper examining a number of aspects of sample preparation and their impact on the success of subsequent LC-MS/MS analysis of broad urine panels.

     

Recent Posts